| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein serine kinase activity | STK26 CDKL3 CDC42BPB CLK1 PRKAA2 PRKCA PRKCG OXSR1 PRKX PRKY DCLK1 | 3.22e-05 | 363 | 133 | 11 | GO:0106310 |
| GeneOntologyMolecularFunction | calcium,diacylglycerol-dependent serine/threonine kinase activity | 4.40e-05 | 2 | 133 | 2 | GO:0004698 | |
| GeneOntologyMolecularFunction | protein kinase activity | NPR2 STK26 CDKL3 CDC42BPB PTK2 CLK1 PRKAA2 PRKCA PRKCG OXSR1 PRKX PRKY DCLK1 | 1.89e-04 | 600 | 133 | 13 | GO:0004672 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | STK26 CDKL3 CDC42BPB CLK1 PRKAA2 PRKCA PRKCG OXSR1 PRKX PRKY DCLK1 | 2.00e-04 | 446 | 133 | 11 | GO:0004674 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF142 ZNF175 NSD1 ZNF208 ZNF217 ZNF510 SIX3 ADNP ZIM3 ZNF568 ZNF440 ZNF710 ZNF711 ZNF34 NCOR1 ZNF728 ZNF540 ZFP1 ZNF667 FOXO4 ZFHX3 ZNF548 | 2.49e-04 | 1459 | 133 | 22 | GO:0000977 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 7.51e-04 | 441 | 133 | 10 | GO:0016887 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | RAD51C KIF18A MYO1H DNAH2 NVL ABCC11 CCT7 CHD3 DHX8 IFIH1 ABCC12 ASCC3 | 8.36e-04 | 614 | 133 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | cAMP-dependent protein kinase activity | 9.05e-04 | 7 | 133 | 2 | GO:0004691 | |
| GeneOntologyMolecularFunction | sphingosine N-acyltransferase activity | 9.05e-04 | 7 | 133 | 2 | GO:0050291 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | NPR2 STK26 CDKL3 CDC42BPB PTK2 CLK1 PRKAA2 PRKCA PRKCG OXSR1 PRKX PRKY DCLK1 | 9.14e-04 | 709 | 133 | 13 | GO:0016773 |
| GeneOntologyBiologicalProcess | protein localization to nucleus | FLNA RANBP2 SYNE1 NVL CCT7 SIN3A SIX3 TERT NF1 CIZ1 PARP9 DCLK1 | 3.76e-06 | 362 | 132 | 12 | GO:0034504 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | RANBP2 PRMT8 SLF1 CAPN3 NSD1 KIAA1586 INPP5F ADNP CDC42BPB PTK2 IFIH1 CLK1 PRKAA2 PRKCA PRKCG PARP9 OXSR1 PRKX DCLK1 | 1.46e-05 | 976 | 132 | 19 | GO:0018193 |
| GeneOntologyBiologicalProcess | axon development | CERS2 FLNA NPR2 WDR36 CDKL3 NCAM2 SIN3A INPP5F ADNP PTK2 NTN4 DST SEMA6D PRKCA DCLK1 | 1.58e-05 | 642 | 132 | 15 | GO:0061564 |
| GeneOntologyBiologicalProcess | regulation of protein localization to nucleus | 1.80e-05 | 176 | 132 | 8 | GO:1900180 | |
| GeneOntologyBiologicalProcess | protein sumoylation | 9.23e-05 | 71 | 132 | 5 | GO:0016925 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 1.09e-04 | 169 | 132 | 7 | GO:0010977 | |
| GeneOntologyCellularComponent | nuclear body | RBBP6 NCAM2 CHD3 ZNF217 DZIP1 AAGAB TERT PALB2 PTK2 DHX8 SRRT GARIN3 PRKAA2 FOXO4 ZFHX3 CDT1 ASCC3 SDCBP2 | 1.71e-05 | 903 | 133 | 18 | GO:0016604 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF142 PHF20 ZNF155 ZNF175 ZNF208 ZNF217 ZNF510 DZIP1 ADNP ZIM3 ZNF568 ZNF440 ZNF710 ZNF711 ZC3H7A ZNF34 ZNF728 ZNF540 ZFP1 ZNF667 CIZ1 ZFHX3 ZNF548 | 5.99e-09 | 777 | 133 | 23 | PS00028 |
| Domain | Znf_C2H2-like | ZNF142 PHF20 ZNF155 ZNF175 ZNF208 ZNF217 ZNF510 DZIP1 ADNP ZIM3 ZNF568 ZNF440 ZNF710 ZNF711 ZC3H7A ZNF34 ZNF728 ZNF540 ZFP1 ZNF667 CIZ1 ZFHX3 ZNF548 | 9.42e-09 | 796 | 133 | 23 | IPR015880 |
| Domain | Znf_C2H2 | ZNF142 PHF20 ZNF155 ZNF175 ZNF208 ZNF217 ZNF510 DZIP1 ADNP ZIM3 ZNF568 ZNF440 ZNF710 ZNF711 ZC3H7A ZNF34 ZNF728 ZNF540 ZFP1 ZNF667 CIZ1 ZFHX3 ZNF548 | 1.16e-08 | 805 | 133 | 23 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF142 PHF20 ZNF155 ZNF175 ZNF208 ZNF217 ZNF510 DZIP1 ADNP ZIM3 ZNF568 ZNF440 ZNF710 ZNF711 ZC3H7A ZNF34 ZNF728 ZNF540 ZFP1 ZNF667 CIZ1 ZFHX3 ZNF548 | 1.24e-08 | 808 | 133 | 23 | SM00355 |
| Domain | zf-C2H2 | ZNF142 PHF20 ZNF155 ZNF175 ZNF208 ZNF217 ZNF510 DZIP1 ADNP ZIM3 ZNF568 ZNF440 ZNF710 ZNF711 ZNF34 ZNF728 ZNF540 ZFP1 ZNF667 ZFHX3 ZNF548 | 1.99e-08 | 693 | 133 | 21 | PF00096 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF142 PHF20 ZNF155 ZNF175 ZNF208 ZNF217 ZNF510 DZIP1 ADNP ZIM3 ZNF568 ZNF440 ZNF710 ZNF711 ZC3H7A ZNF34 ZNF728 ZNF540 ZFP1 ZNF667 ZFHX3 ZNF548 | 2.83e-08 | 775 | 133 | 22 | PS50157 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF142 ZNF155 ZNF175 ZNF208 ZNF217 ZNF510 DZIP1 ADNP ZIM3 ZNF568 ZNF440 ZNF710 ZNF711 ZNF34 ZNF728 ZNF540 ZFP1 ZNF667 ZFHX3 ZNF548 | 1.02e-07 | 694 | 133 | 20 | IPR013087 |
| Domain | - | ZNF142 ZNF155 ZNF175 ZNF208 ZNF217 ZNF510 DZIP1 ZIM3 ZNF568 ZNF440 ZNF710 ZNF711 ZNF34 ZNF728 ZNF540 ZFP1 ZNF667 ZFHX3 ZNF548 | 3.46e-07 | 679 | 133 | 19 | 3.30.160.60 |
| Domain | KRAB | ZNF155 ZNF175 ZNF208 ZNF510 ZIM3 ZNF568 ZNF440 ZNF34 ZNF728 ZNF540 ZFP1 ZNF667 ZNF548 | 1.71e-06 | 358 | 133 | 13 | PS50805 |
| Domain | KRAB | ZNF155 ZNF175 ZNF208 ZNF510 ZIM3 ZNF568 ZNF440 ZNF34 ZNF728 ZNF540 ZFP1 ZNF667 ZNF548 | 1.71e-06 | 358 | 133 | 13 | PF01352 |
| Domain | KRAB | ZNF155 ZNF175 ZNF208 ZNF510 ZIM3 ZNF568 ZNF440 ZNF34 ZNF728 ZNF540 ZFP1 ZNF667 ZNF548 | 2.39e-06 | 369 | 133 | 13 | SM00349 |
| Domain | KRAB | ZNF155 ZNF175 ZNF208 ZNF510 ZIM3 ZNF568 ZNF440 ZNF34 ZNF728 ZNF540 ZFP1 ZNF667 ZNF548 | 2.46e-06 | 370 | 133 | 13 | IPR001909 |
| Domain | Pkinase | NPR2 STK26 CDKL3 CDC42BPB CLK1 PRKAA2 PRKCA PRKCG OXSR1 PRKX PRKY DCLK1 | 1.83e-05 | 381 | 133 | 12 | PF00069 |
| Domain | Kinase-like_dom | NPR2 STK26 CDKL3 CDC42BPB PTK2 DST CLK1 PRKAA2 PRKCA PRKCG OXSR1 PRKX PRKY DCLK1 | 3.28e-05 | 542 | 133 | 14 | IPR011009 |
| Domain | Prot_kinase_dom | NPR2 STK26 CDKL3 CDC42BPB PTK2 CLK1 PRKAA2 PRKCA PRKCG OXSR1 PRKX PRKY DCLK1 | 4.75e-05 | 489 | 133 | 13 | IPR000719 |
| Domain | ASH | 5.03e-05 | 2 | 133 | 2 | IPR031549 | |
| Domain | ASH | 5.03e-05 | 2 | 133 | 2 | PF15780 | |
| Domain | PROTEIN_KINASE_DOM | NPR2 STK26 CDKL3 CDC42BPB PTK2 CLK1 PRKAA2 PRKCA PRKCG OXSR1 PRKX PRKY DCLK1 | 5.16e-05 | 493 | 133 | 13 | PS50011 |
| Domain | S_TKc | STK26 CDKL3 CDC42BPB CLK1 PRKAA2 PRKCA PRKCG OXSR1 PRKX PRKY DCLK1 | 5.30e-05 | 359 | 133 | 11 | SM00220 |
| Domain | PROTEIN_KINASE_ST | STK26 CDKL3 CDC42BPB CLK1 PRKAA2 PRKCA PRKCG OXSR1 PRKX PRKY DCLK1 | 5.71e-05 | 362 | 133 | 11 | PS00108 |
| Domain | zf-C2H2_6 | ZNF155 ZNF208 ZIM3 ZNF568 ZNF440 ZNF710 ZNF728 ZNF540 ZNF667 ZNF548 | 8.51e-05 | 314 | 133 | 10 | PF13912 |
| Domain | Protein_kinase_ATP_BS | STK26 CDKL3 CDC42BPB PTK2 CLK1 PRKAA2 PRKCA PRKCG OXSR1 PRKX DCLK1 | 8.60e-05 | 379 | 133 | 11 | IPR017441 |
| Domain | PROTEIN_KINASE_ATP | STK26 CDKL3 CDC42BPB PTK2 CLK1 PRKAA2 PRKCA PRKCG OXSR1 PRKX PRKY DCLK1 | 1.10e-04 | 459 | 133 | 12 | PS00107 |
| Domain | Protein_kinase_C_a/b/g | 1.50e-04 | 3 | 133 | 2 | IPR014375 | |
| Domain | Ser/Thr_kinase_AS | CDKL3 CDC42BPB CLK1 PRKAA2 PRKCA PRKCG OXSR1 PRKX PRKY DCLK1 | 2.42e-04 | 357 | 133 | 10 | IPR008271 |
| Domain | DAG/PE-bd | 4.27e-04 | 21 | 133 | 3 | IPR020454 | |
| Domain | PolyA | 4.96e-04 | 5 | 133 | 2 | SM00517 | |
| Domain | - | 4.96e-04 | 5 | 133 | 2 | 1.10.1900.10 | |
| Domain | PABP | 4.96e-04 | 5 | 133 | 2 | PF00658 | |
| Domain | Cu-oxidase_3 | 4.96e-04 | 5 | 133 | 2 | IPR011707 | |
| Domain | PABP_1234 | 4.96e-04 | 5 | 133 | 2 | IPR006515 | |
| Domain | MULTICOPPER_OXIDASE1 | 4.96e-04 | 5 | 133 | 2 | PS00079 | |
| Domain | Cu_oxidase_CS | 4.96e-04 | 5 | 133 | 2 | IPR033138 | |
| Domain | PABC | 4.96e-04 | 5 | 133 | 2 | PS51309 | |
| Domain | PABP_HYD | 4.96e-04 | 5 | 133 | 2 | IPR002004 | |
| Domain | Cu-oxidase_3 | 4.96e-04 | 5 | 133 | 2 | PF07732 | |
| Domain | ACTININ_2 | 5.63e-04 | 23 | 133 | 3 | PS00020 | |
| Domain | ACTININ_1 | 5.63e-04 | 23 | 133 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 5.63e-04 | 23 | 133 | 3 | IPR001589 | |
| Domain | AAA | 5.81e-04 | 144 | 133 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 5.81e-04 | 144 | 133 | 6 | IPR003593 | |
| Domain | AGC-kinase_C | 6.78e-04 | 56 | 133 | 4 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 6.78e-04 | 56 | 133 | 4 | PS51285 | |
| Domain | S_TK_X | 6.78e-04 | 56 | 133 | 4 | SM00133 | |
| Domain | Cu_oxidase_Cu_BS | 7.41e-04 | 6 | 133 | 2 | IPR002355 | |
| Domain | Lag1/Lac1 | 7.41e-04 | 6 | 133 | 2 | IPR016439 | |
| Domain | CH | 1.19e-03 | 65 | 133 | 4 | SM00033 | |
| Domain | CH | 1.57e-03 | 70 | 133 | 4 | PF00307 | |
| Domain | - | 1.65e-03 | 71 | 133 | 4 | 1.10.418.10 | |
| Domain | CH | 1.83e-03 | 73 | 133 | 4 | PS50021 | |
| Domain | CH-domain | 2.02e-03 | 75 | 133 | 4 | IPR001715 | |
| Domain | Pkinase_C | 2.30e-03 | 37 | 133 | 3 | IPR017892 | |
| Domain | Homeodomain-like | 2.63e-03 | 332 | 133 | 8 | IPR009057 | |
| Domain | P-loop_NTPase | RAD51C KIF18A DNAH2 NVL ABCC11 CHD3 AAGAB GSPT1 DHX8 IFIH1 ASPM ABCC12 ASCC3 HYDIN | 2.91e-03 | 848 | 133 | 14 | IPR027417 |
| Domain | Pkinase_C | 3.31e-03 | 42 | 133 | 3 | PF00433 | |
| Domain | - | 4.19e-03 | 283 | 133 | 7 | 1.10.10.60 | |
| Domain | - | 4.33e-03 | 14 | 133 | 2 | 2.60.40.420 | |
| Domain | Galactose-bd-like | 4.57e-03 | 94 | 133 | 4 | IPR008979 | |
| Domain | TLC | 5.66e-03 | 16 | 133 | 2 | SM00724 | |
| Domain | TLC | 5.66e-03 | 16 | 133 | 2 | PS50922 | |
| Domain | TRAM_LAG1_CLN8 | 5.66e-03 | 16 | 133 | 2 | PF03798 | |
| Domain | TLC-dom | 5.66e-03 | 16 | 133 | 2 | IPR006634 | |
| Domain | - | RAD51C DNAH2 NVL ABCC11 CHD3 AAGAB GSPT1 DHX8 IFIH1 ABCC12 ASCC3 HYDIN | 7.04e-03 | 746 | 133 | 12 | 3.40.50.300 |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US27_TO_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY | 2.13e-05 | 8 | 104 | 3 | M47555 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY | 4.51e-05 | 10 | 104 | 3 | M47644 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE | 4.99e-05 | 28 | 104 | 4 | M42536 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | PHF20 ZNF155 ZNF175 ZNF208 CHD3 ZNF510 SIN3A GRIN2A ZIM3 ZNF568 ZNF440 ZNF710 ZNF711 SRRT ZNF34 NCOR1 ZNF540 PRKAA2 ZFP1 ZNF667 FOXO4 ZFHX3 TAF2 ZNF548 | 5.58e-05 | 1387 | 104 | 24 | M734 |
| Pathway | KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY | 6.17e-05 | 11 | 104 | 3 | M47637 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY | 7.55e-05 | 31 | 104 | 4 | M47554 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY | 8.18e-05 | 12 | 104 | 3 | M47649 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY | 8.18e-05 | 12 | 104 | 3 | M47628 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.06e-04 | 13 | 104 | 3 | M47656 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 1.64e-04 | 70 | 104 | 5 | M3115 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY | 3.47e-04 | 19 | 104 | 3 | M47596 | |
| Pubmed | CERS2 RANBP2 SERBP1 WDR36 RBBP6 SYNE1 PABPC4 NSD1 CCT7 ZNF217 CDC42BPB DHX8 GREB1L SRRT ZC3H7A DST MRPS17 CIZ1 ZFHX3 TAF2 HERC2 ASCC3 DCLK1 EPB41L2 MAN1B1 | 5.62e-10 | 1497 | 134 | 25 | 31527615 | |
| Pubmed | FLNA RANBP2 ANKFY1 CHD3 ZNF217 INPP5F ECPAS ADNP PALB2 GREB1L NCOR1 DST ZFHX3 ASCC3 | 9.77e-10 | 418 | 134 | 14 | 34709266 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | RALGAPA1 PRMT8 SYNE1 NCAM2 GRIN2A PTK2 NF1 PRKCA PRKCG AKAP11 DCLK1 EPB41L2 | 1.07e-09 | 281 | 134 | 12 | 28706196 |
| Pubmed | FLNA RANBP2 SERBP1 WDR36 PABPC4 NVL NSD1 ECPAS ADNP DHX8 CEP170 DST NF1 HERC2 ASCC3 EPB41L2 | 5.22e-09 | 653 | 134 | 16 | 22586326 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | KIF18A RPL31 SERBP1 WDR36 RBBP6 PABPC4 NVL CHD3 SIN3A DHX8 CEP170 SRRT ZC3H7A NEMF ASPM HERC2 ASCC3 | 6.34e-09 | 759 | 134 | 17 | 35915203 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNA RANBP2 WDR36 SYNE1 PABPC4 CCT7 CHD3 ADNP F5 DHX8 CEP170 SRRT DST NF1 CIZ1 PRKCA HERC2 ASCC3 EPB41L2 | 1.59e-08 | 1024 | 134 | 19 | 24711643 |
| Pubmed | RALGAPA1 FLNA RPL31 SERBP1 ARHGAP23 SYNE1 STK26 PABPC4 NCAM2 CCT7 CHD3 GRIN2A CDC42BPB CEP170 SRRT DST NF1 MAP7D2 PRKCA PRKCG DCLK1 EPB41L2 | 3.04e-08 | 1431 | 134 | 22 | 37142655 | |
| Pubmed | 5.14e-08 | 250 | 134 | 10 | 33536335 | ||
| Pubmed | FLNA RANBP2 ZNF142 RBBP6 ZNF175 SYNE1 CDC42BPB PTK2 ZNF440 ZC3H7A DST HERC2 EPB41L2 | 5.63e-08 | 486 | 134 | 13 | 20936779 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.63e-07 | 283 | 134 | 10 | 30585729 | |
| Pubmed | RANBP2 ANKFY1 SYNE1 NSD1 GRIN2A ADNP CDC42BPB PTK2 CEP170 NCOR1 DST NF1 PRKCA PRKCG HERC2 DCLK1 EPB41L2 | 1.95e-07 | 963 | 134 | 17 | 28671696 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNA RANBP2 RPL31 ANKFY1 WDR36 ARHGAP23 CCT7 ADNP PTK2 GSPT1 SRRT ZC3H7A DST NF1 ASPM PRKCA TAF2 HERC2 ASCC3 EPB41L2 | 2.59e-07 | 1353 | 134 | 20 | 29467282 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | RANBP2 RPL31 ARHGAP23 NVL CCT7 F5 PTK2 SRRT NCOR1 NF1 NEMF HERC2 | 3.43e-07 | 475 | 134 | 12 | 31040226 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLNA RANBP2 RPL31 SERBP1 ANKFY1 WDR36 SYNE1 PABPC4 CCT7 ECPAS ADNP GSPT1 DHX8 SRRT MFGE8 NF1 SEC11A PRKAA2 NEMF EPB41L2 | 5.85e-07 | 1425 | 134 | 20 | 30948266 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | FLNA RANBP2 SERBP1 PABPC4 CPED1 CDC42BPB PTK2 GSPT1 DHX8 CEP170 ZC3H7A OXSR1 TAF2 ASCC3 | 8.69e-07 | 724 | 134 | 14 | 36232890 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | FLNA RANBP2 SERBP1 SLF1 WDR36 RBBP6 PABPC4 NVL NSD1 CHD3 ADNP ZNF711 CEP170 SRRT NCOR1 CIZ1 | 9.00e-07 | 954 | 134 | 16 | 36373674 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 KIAA0930 DZIP1 INPP5F CEP170 SRRT DST NF1 CEP89 PRKAA2 PRKCG AKAP11 FOXO4 DCLK1 EPB41L2 | 1.27e-06 | 861 | 134 | 15 | 36931259 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FLNA RANBP2 RBBP6 CHD3 ZNF217 SIN3A ECPAS PALB2 SRRT NCOR1 NF1 CDT1 OXSR1 EPB41L2 | 1.90e-06 | 774 | 134 | 14 | 15302935 |
| Pubmed | 1.94e-06 | 7 | 134 | 3 | 12147342 | ||
| Pubmed | RANBP2 WDR36 RBBP6 PABPC4 CHD3 SIN3A ARMCX3 CDT1 TAF2 ASCC3 HYDIN | 2.21e-06 | 469 | 134 | 11 | 27634302 | |
| Pubmed | 3.08e-06 | 103 | 134 | 6 | 32744500 | ||
| Pubmed | RANBP2 ANKFY1 SYNE1 CAPN3 DZIP1 CDC42BPB ZNF711 CEP170 NCOR1 DST CLK1 | 3.85e-06 | 497 | 134 | 11 | 23414517 | |
| Pubmed | 5.77e-06 | 330 | 134 | 9 | 32529326 | ||
| Pubmed | 6.06e-06 | 332 | 134 | 9 | 37433992 | ||
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 7.66e-06 | 258 | 134 | 8 | 37794589 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 8.57e-06 | 440 | 134 | 10 | 34244565 | |
| Pubmed | FLNA SERBP1 RBBP6 NSD1 SIN3A ADNP CEP170 NCOR1 CIZ1 TAF2 ASCC3 | 9.83e-06 | 549 | 134 | 11 | 38280479 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CERS2 RANBP2 RPL31 SLF1 WDR36 PHF20 RBBP6 NSD1 CHD3 SIN3A ADNP PALB2 DHX8 SRRT NCOR1 DST CIZ1 | 1.05e-05 | 1294 | 134 | 17 | 30804502 |
| Pubmed | 1.40e-05 | 38 | 134 | 4 | 33283408 | ||
| Pubmed | 1.41e-05 | 202 | 134 | 7 | 24639526 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 7633447 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 12954613 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 37059182 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 36914641 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 33920284 | ||
| Pubmed | Man to mouse--lessons learned from the distal end of the human X chromosome. | 1.47e-05 | 2 | 134 | 2 | 9414316 | |
| Pubmed | Profiles of PrKX expression in developmental mouse embryo and human tissues. | 1.47e-05 | 2 | 134 | 2 | 15879576 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 30348826 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 21684272 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 9302280 | ||
| Pubmed | Neurofibromin physically interacts with the N-terminal domain of focal adhesion kinase. | 1.47e-05 | 2 | 134 | 2 | 19479903 | |
| Pubmed | Ceramide synthase 2 facilitates S1P-dependent egress of thymocytes into the circulation in mice. | 1.47e-05 | 2 | 134 | 2 | 28198542 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 26139604 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 16979586 | ||
| Pubmed | Multiple splicing variants of two new human ATP-binding cassette transporters, ABCC11 and ABCC12. | 1.47e-05 | 2 | 134 | 2 | 11688999 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 21976518 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 15590069 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 34124795 | ||
| Pubmed | Conventional PKCs regulate the temporal pattern of Ca2+ oscillations at fertilization in mouse eggs. | 1.47e-05 | 2 | 134 | 2 | 15051735 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 11483364 | ||
| Pubmed | A novel murine PKA-related protein kinase involved in neuronal differentiation. | 1.47e-05 | 2 | 134 | 2 | 10729225 | |
| Pubmed | The AAA-ATPase NVL2 is a telomerase component essential for holoenzyme assembly. | 1.47e-05 | 2 | 134 | 2 | 22226966 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | FLNA RANBP2 SERBP1 WDR36 RBBP6 CCT7 CHD3 SIN3A ADNP CEP170 DST ZNF667 CIZ1 EPB41L2 | 1.60e-05 | 934 | 134 | 14 | 33916271 |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | RANBP2 RBBP6 STK26 PABPC4 CDKL3 ZNF510 CRHR1 PTK2 DHX8 CLK1 AKAP11 HERC2 | 1.69e-05 | 695 | 134 | 12 | 23602568 |
| Pubmed | RALGAPA1 WDR36 SYNE1 NVL SHMT1 DZIP1 CDC42BPB TBC1D17 ZC3H7A CEP89 MRPS17 CIZ1 ASPM MAP7D2 AKAP11 HERC2 ASCC3 EPB41L2 | 1.71e-05 | 1487 | 134 | 18 | 33957083 | |
| Pubmed | RALGAPA1 RANBP2 RPL31 SERBP1 PABPC4 CCT7 ECPAS CEP170 DST SEC11A ASCC3 EPB41L2 | 2.03e-05 | 708 | 134 | 12 | 39231216 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 2.52e-05 | 608 | 134 | 11 | 36089195 | |
| Pubmed | FLNA RANBP2 RPL31 SERBP1 RBBP6 STK26 PABPC4 CCT7 ZNF217 GSPT1 DHX8 SRRT NCOR1 NEMF OXSR1 ASCC3 | 2.60e-05 | 1247 | 134 | 16 | 27684187 | |
| Pubmed | CAPN3 DNAH2 NSD1 SHMT1 INPP5F CDC42BPB PTK2 GSPT1 CLK1 PRKCA PRKCG OXSR1 | 2.73e-05 | 730 | 134 | 12 | 34857952 | |
| Pubmed | 2.86e-05 | 152 | 134 | 6 | 16009940 | ||
| Pubmed | 3.63e-05 | 234 | 134 | 7 | 36243803 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | CERS2 RANBP2 RPL31 KIAA0930 SERBP1 PABPC4 ECPAS CDC42BPB PTK2 SRRT SEC11A ASPM AKAP11 OXSR1 HERC2 EPB41L2 | 3.69e-05 | 1284 | 134 | 16 | 17353931 |
| Pubmed | RPL31 SLF1 RBBP6 PABPC4 CCT7 CHD3 ZNF217 SIN3A ADNP SRRT NCOR1 DST MRPS17 ZFHX3 PABPC1L TAF2 HERC2 | 3.71e-05 | 1429 | 134 | 17 | 35140242 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | RALGAPA1 WDR36 PABPC4 NVL ECPAS ARMCX3 GSPT1 CEP170 ZC3H7A MFGE8 HERC2 ASCC3 | 3.74e-05 | 754 | 134 | 12 | 33060197 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | FLNA RANBP2 RPL31 SERBP1 STK26 PABPC4 SHMT1 CCT7 ECPAS GSPT1 CEP170 DST NEMF ASCC3 EPB41L2 | 3.88e-05 | 1149 | 134 | 15 | 35446349 |
| Pubmed | FLNA RANBP2 RPL31 ANKFY1 STK26 CCT7 SIN3A ECPAS GSPT1 ASCC3 EPB41L2 | 3.90e-05 | 638 | 134 | 11 | 33239621 | |
| Pubmed | RANBP2 SERBP1 WDR36 RBBP6 NVL CCT7 CHD3 SIN3A ECPAS ADNP SRRT NCOR1 OXSR1 TAF2 | 3.92e-05 | 1014 | 134 | 14 | 32416067 | |
| Pubmed | FLNA NVL CEP170 ZNF34 NTN4 MFGE8 DST NF1 GFOD1 SEC11A ZFP1 FOXO4 PARP9 SDCBP2 ZNF548 HYDIN | 4.01e-05 | 1293 | 134 | 16 | 15342556 | |
| Pubmed | 4.37e-05 | 18 | 134 | 3 | 12493763 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 14966364 | ||
| Pubmed | Protein kinase C as a molecular machine for decoding calcium and diacylglycerol signals. | 4.41e-05 | 3 | 134 | 2 | 9814702 | |
| Pubmed | Eleven residues determine the acyl chain specificity of ceramide synthases. | 4.41e-05 | 3 | 134 | 2 | 29632068 | |
| Pubmed | Whole exome sequencing of ENU-induced thrombosis modifier mutations in the mouse. | 4.41e-05 | 3 | 134 | 2 | 30188893 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 33634976 | ||
| Pubmed | A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. | 4.41e-05 | 3 | 134 | 2 | 9139820 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 11104776 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 31365169 | ||
| Pubmed | Neurofibromin binds to caveolin-1 and regulates ras, FAK, and Akt. | 4.41e-05 | 3 | 134 | 2 | 16405917 | |
| Pubmed | NFX1 interacts with mSin3A/histone deacetylase to repress hTERT transcription in keratinocytes. | 4.41e-05 | 3 | 134 | 2 | 18505829 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 28796317 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 12704190 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 17980165 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 9154127 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 27328445 | ||
| Pubmed | Protein and molecular characterization of hippocampal protein kinase C in C57BL/6 and DBA/2 mice. | 4.41e-05 | 3 | 134 | 2 | 7760054 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 21409391 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 22819675 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 3755548 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 29988077 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 1714454 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 22898813 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 19895572 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 19556521 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 28024868 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 12505151 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 27307229 | ||
| Pubmed | 4.66e-05 | 332 | 134 | 8 | 25693804 | ||
| Pubmed | CERS2 FLNA RANBP2 RPL31 SERBP1 NVL ECPAS F5 NCOR1 MFGE8 NF1 PARP9 HERC2 ASCC3 MAN1B1 | 4.68e-05 | 1168 | 134 | 15 | 19946888 | |
| Pubmed | A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. | 4.73e-05 | 431 | 134 | 9 | 33660365 | |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | 4.81e-05 | 432 | 134 | 9 | 23455922 | |
| Interaction | AGAP2 interactions | RALGAPA1 PRMT8 SYNE1 NCAM2 GRIN2A PTK2 NF1 PRKCA PRKCG DCLK1 EPB41L2 | 1.62e-07 | 210 | 134 | 11 | int:AGAP2 |
| Interaction | NUP43 interactions | FLNA RANBP2 WDR36 RBBP6 NSD1 CCT7 CHD3 DHX8 ZNF711 CRYAA SRRT NCOR1 DST CIZ1 ZFHX3 TAF2 | 4.15e-06 | 625 | 134 | 16 | int:NUP43 |
| Interaction | RCOR1 interactions | FLNA RANBP2 ANKFY1 CHD3 ZNF217 SIN3A ECPAS PALB2 GSPT1 CRYAA NCOR1 DST ZFHX3 ASCC3 | 5.48e-06 | 494 | 134 | 14 | int:RCOR1 |
| Interaction | HECTD1 interactions | KIF18A RPL31 SERBP1 WDR36 RBBP6 PABPC4 NVL CCT7 CHD3 SIN3A DHX8 CEP170 SRRT ZC3H7A NEMF ASPM CDT1 HERC2 ASCC3 | 2.79e-05 | 984 | 134 | 19 | int:HECTD1 |
| Interaction | ZCCHC10 interactions | 2.92e-05 | 236 | 134 | 9 | int:ZCCHC10 | |
| Interaction | CLIP1 interactions | 3.12e-05 | 183 | 134 | 8 | int:CLIP1 | |
| Interaction | CCDC8 interactions | DOK6 FLNA RANBP2 PABPC4 CCT7 CHD3 ADNP F5 CEP170 DST NF1 PRKCA HERC2 ASCC3 EPB41L2 | 3.17e-05 | 656 | 134 | 15 | int:CCDC8 |
| Interaction | SIRT7 interactions | FLNA RANBP2 SERBP1 WDR36 PABPC4 NVL NSD1 ECPAS ADNP DHX8 CEP170 DST NF1 HERC2 ASCC3 EPB41L2 | 3.56e-05 | 744 | 134 | 16 | int:SIRT7 |
| Interaction | YWHAB interactions | RALGAPA1 KIAA0930 SERBP1 ARHGAP23 PABPC4 NCAM2 DZIP1 INPP5F CEP170 DST NF1 CEP89 SEC11A PRKAA2 PRKCG AKAP11 FOXO4 DCLK1 EPB41L2 | 4.20e-05 | 1014 | 134 | 19 | int:YWHAB |
| Interaction | DCAF8 interactions | 6.84e-05 | 151 | 134 | 7 | int:DCAF8 | |
| Interaction | PPP1CB interactions | KIF18A FLNA SERBP1 STK26 CHD3 PTK2 GSPT1 NCOR1 DST CLK1 AKAP11 TAF2 | 7.11e-05 | 469 | 134 | 12 | int:PPP1CB |
| Interaction | YWHAG interactions | RALGAPA1 FLNA KIAA0930 SERBP1 ARHGAP23 PABPC4 NCAM2 DZIP1 INPP5F PTK2 CEP170 DST NF1 CEP89 CLK1 PRKCA PRKCG AKAP11 FOXO4 DCLK1 EPB41L2 | 7.59e-05 | 1248 | 134 | 21 | int:YWHAG |
| Interaction | HABP4 interactions | 8.40e-05 | 156 | 134 | 7 | int:HABP4 | |
| Interaction | MUS81 interactions | 8.93e-05 | 109 | 134 | 6 | int:MUS81 | |
| Interaction | CEACAM16 interactions | 9.92e-05 | 14 | 134 | 3 | int:CEACAM16 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF142 ZNF155 ZNF175 ZNF208 ZNF217 ZNF510 ZIM3 ZNF568 ZNF440 ZNF710 ZNF711 ZNF34 ZNF728 ZNF540 ZFP1 ZNF667 ZFHX3 ZNF548 | 1.52e-08 | 718 | 91 | 18 | 28 |
| GeneFamily | CERS class homeoboxes | 3.71e-04 | 6 | 91 | 2 | 530 | |
| GeneFamily | C2 domain containing protein kinases | 1.10e-03 | 10 | 91 | 2 | 835 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 1.34e-03 | 11 | 91 | 2 | 1168 | |
| GeneFamily | ATP binding cassette subfamily C | 1.89e-03 | 13 | 91 | 2 | 807 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.21e-03 | 181 | 91 | 5 | 694 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.52e-03 | 15 | 91 | 2 | 529 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 4.49e-03 | 20 | 91 | 2 | 548 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | KIAA0930 SERBP1 ARHGAP23 RBBP6 SYNE1 NCAM2 CHD3 DZIP1 ECPAS MFAP3L BMP1 NCOR1 DST SEMA6D ZFP1 PRKCA ZFHX3 DENND5A DCLK1 CERS4 EPB41L2 | 1.97e-07 | 1102 | 134 | 21 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | KIAA0930 SERBP1 ARHGAP23 RBBP6 SYNE1 NCAM2 CHD3 DZIP1 ECPAS MFAP3L BMP1 NCOR1 DST SEMA6D ZFP1 PRKCA ZFHX3 DENND5A DCLK1 CERS4 EPB41L2 | 2.73e-07 | 1124 | 134 | 21 | MM1070 |
| Coexpression | GSE9037_WT_VS_IRAK4_KO_BMDM_UP | 9.39e-07 | 200 | 134 | 9 | M5812 | |
| Coexpression | SMID_BREAST_CANCER_BASAL_UP | FLNA CP DZIP1 SIX3 CEP170 IFIH1 MFGE8 ASPM PRKCA PLCB4 CDT1 PRKX PRKY EPB41L2 | 7.89e-06 | 662 | 134 | 14 | M8124 |
| Coexpression | GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP | 7.90e-06 | 196 | 134 | 8 | M9241 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RAD51C RANBP2 PHF20 NVL INPP5F ADNP PTK2 CEP170 DST PRKCA AKAP11 ZFHX3 PLCB4 OXSR1 DENND5A ASCC3 | 8.14e-06 | 856 | 134 | 16 | M4500 |
| Coexpression | GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP | 6.28e-05 | 193 | 134 | 7 | M3484 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RALGAPA1 FLNA RANBP2 RPL31 SLF1 PHF20 RBBP6 SYNE1 NSD1 CHD3 ZNF217 SIN3A NCOR1 GFOD1 CLK1 NEMF AKAP11 PARP9 ASCC3 PRKY | 7.19e-05 | 1492 | 134 | 20 | M40023 |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | KIF18A KIAA0930 SERBP1 PABPC4 CCT7 ECPAS PTK2 OSBPL2 CIZ1 ASPM CDT1 MAN1B1 | 7.47e-05 | 612 | 134 | 12 | M4772 |
| Coexpression | GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_DN | 7.86e-05 | 200 | 134 | 7 | M8869 | |
| Coexpression | GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_DN | 7.86e-05 | 200 | 134 | 7 | M6556 | |
| Coexpression | GSE18148_CBFB_KO_VS_WT_TREG_DN | 7.86e-05 | 200 | 134 | 7 | M4252 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 9.37e-09 | 198 | 134 | 9 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 1.71e-07 | 200 | 134 | 8 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 178 | 134 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-06 | 193 | 134 | 7 | a5695ce2e24a62026ae28f3dea07ca4a435206b8 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.52e-06 | 200 | 134 | 7 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.52e-06 | 200 | 134 | 7 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.57e-06 | 155 | 134 | 6 | 8b524c65fa5c901f70c7caae4ec7fd2859eaf227 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.57e-06 | 155 | 134 | 6 | 7fe8b8c0c8a9e3190cfd52d3934509e6780e1717 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.41e-06 | 161 | 134 | 6 | 22fea192cd5f6d3544533d8b10e1d74dfedf0f05 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.20e-05 | 168 | 134 | 6 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-05 | 173 | 134 | 6 | 03b50b2376d353748a32bf14a9fc8341ea61dbca | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-05 | 173 | 134 | 6 | 2978c744d3c8dcaa2b9bb225abf846f82e8f9176 | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-05 | 173 | 134 | 6 | 12da47b90aecedaa31764ff7ddb853ee39123e9d | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-05 | 173 | 134 | 6 | 23d4a315a0ad5c6fc77bcfc18b6c1ff55be99e8f | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-05 | 103 | 134 | 5 | eb9f008b5fb8a01df8ea4faf6e6aebc1a9db9bd3 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.51e-05 | 175 | 134 | 6 | fa16c6ba08dc0cc22e8cf049db0577811d080df6 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.56e-05 | 176 | 134 | 6 | b794275fdd757b8fa2108e3c867f23da2649146d | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 1.72e-05 | 179 | 134 | 6 | 431e1b29015ec817f778499106d24b19cfc825ae | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.95e-05 | 183 | 134 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-05 | 185 | 134 | 6 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.07e-05 | 185 | 134 | 6 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-05 | 185 | 134 | 6 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.13e-05 | 186 | 134 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.13e-05 | 186 | 134 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-05 | 111 | 134 | 5 | dfbdeadad321392d359e6fb7112b28b043a4b874 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-05 | 190 | 134 | 6 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-05 | 190 | 134 | 6 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 195 | 134 | 6 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-05 | 195 | 134 | 6 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 195 | 134 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 3.03e-05 | 198 | 134 | 6 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 3.03e-05 | 198 | 134 | 6 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 3.11e-05 | 199 | 134 | 6 | b2d7dea11207cca63d688f8051143850b29dbdf0 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.20e-05 | 200 | 134 | 6 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.20e-05 | 200 | 134 | 6 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | MS-CD4-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 9.69e-05 | 152 | 134 | 5 | b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-04 | 154 | 134 | 5 | 1f8d127b657976656e4ec292f26d619943533b86 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 160 | 134 | 5 | c2b5fadb4bac17fafc08831f6d3f4ff96ada7e70 | |
| ToppCell | COPD-Lymphoid-ILC_B|Lymphoid / Disease state, Lineage and Cell class | 1.46e-04 | 166 | 134 | 5 | e2cad1db536d5ad5a34c337c19b5e7d1a2851552 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.51e-04 | 167 | 134 | 5 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.51e-04 | 167 | 134 | 5 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-04 | 169 | 134 | 5 | 7cb1b87be66a22fe5731bb1b55bc515920fe3e8b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 170 | 134 | 5 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 170 | 134 | 5 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 170 | 134 | 5 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.73e-04 | 172 | 134 | 5 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 1.77e-04 | 173 | 134 | 5 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-04 | 177 | 134 | 5 | 946803293a7955116c80f403e99e4093e798ca3f | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 1.97e-04 | 177 | 134 | 5 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.97e-04 | 177 | 134 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-04 | 183 | 134 | 5 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.30e-04 | 183 | 134 | 5 | 58847e8f3a7ce3e33adba9477bcd55e769a64a90 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.30e-04 | 183 | 134 | 5 | e84539978ab4de42e19186aed00f24bb50cbc21f | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.36e-04 | 184 | 134 | 5 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.36e-04 | 184 | 134 | 5 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 2.36e-04 | 184 | 134 | 5 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-04 | 184 | 134 | 5 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.36e-04 | 184 | 134 | 5 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 184 | 134 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.36e-04 | 184 | 134 | 5 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 2.36e-04 | 184 | 134 | 5 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-04 | 185 | 134 | 5 | 7092436b4db90289516ed130ade596e3021cffaf | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.42e-04 | 185 | 134 | 5 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.42e-04 | 185 | 134 | 5 | 0094f9baddb20214d2a2c166f1637d1a9cf1169a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-04 | 185 | 134 | 5 | a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.48e-04 | 186 | 134 | 5 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 186 | 134 | 5 | 4ae3c0fe8640a8d029875cf3f0f5ffbba38e85f8 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-04 | 187 | 134 | 5 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-04 | 187 | 134 | 5 | accb8a78b885703a27d4b560f0053f03d82ff3af | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.54e-04 | 187 | 134 | 5 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.54e-04 | 187 | 134 | 5 | e61c1755531469dd3850c9740474b5ad4e0499c1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-04 | 188 | 134 | 5 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-04 | 189 | 134 | 5 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.67e-04 | 189 | 134 | 5 | b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.67e-04 | 189 | 134 | 5 | 26cfe5b7e7f477f225f4e9f25f983f432f01e183 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-04 | 189 | 134 | 5 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.74e-04 | 190 | 134 | 5 | 2ab604d35456beba71c25511e0f819000e6642d2 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.74e-04 | 190 | 134 | 5 | 6ea9fa08bd97bedcb21d3654467e7f8dd74c8fd0 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.74e-04 | 190 | 134 | 5 | 106862ef44fcaa0971c3ba0147d13eb08015ca77 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-04 | 190 | 134 | 5 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.74e-04 | 190 | 134 | 5 | 10b02c62e72bfea9767e3e751011436925da823e | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.74e-04 | 190 | 134 | 5 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.74e-04 | 190 | 134 | 5 | 84fbd5664ec886120963d4f50dfa1fd1851d36c1 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.74e-04 | 190 | 134 | 5 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-04 | 191 | 134 | 5 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.81e-04 | 191 | 134 | 5 | cd709bbcd320373468ea7f058ee5fda8a067b5d0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.81e-04 | 191 | 134 | 5 | 14851529025cfc2b665f71ebad04150ec543da7a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-04 | 191 | 134 | 5 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.81e-04 | 191 | 134 | 5 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-04 | 191 | 134 | 5 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.81e-04 | 191 | 134 | 5 | 2ad717b59215ad8d933e9637d363b65d7298e5d4 | |
| Drug | Nabumetone [42924-53-8]; Down 200; 17.6uM; HL60; HT_HG-U133A | NPR2 PHF20 ZNF155 CYP17A1 SHMT1 TERT ZNF710 ZFHX3 PLCB4 RWDD2A | 2.45e-07 | 195 | 134 | 10 | 3108_DN |
| Drug | Pentoxifylline [6493-05-6]; Up 200; 14.4uM; PC3; HT_HG-U133A | KIAA0930 CHD3 ZNF510 DZIP1 AAGAB ZNF710 BMP1 MFGE8 CDT1 RWDD2A | 3.10e-07 | 200 | 134 | 10 | 2127_UP |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; PC3; HT_HG-U133A | 2.60e-06 | 197 | 134 | 9 | 7138_UP | |
| Drug | Methionine sulfoximine (L) [15985-39-4]; Down 200; 22.2uM; PC3; HT_HG-U133A | 2.71e-06 | 198 | 134 | 9 | 4070_DN | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.86e-05 | 192 | 134 | 8 | 7280_DN | |
| Drug | Pyrithyldione [77-04-3]; Down 200; 24uM; PC3; HT_HG-U133A | 1.93e-05 | 193 | 134 | 8 | 7153_DN | |
| Drug | Alprenolol hydrochloride [13707-88-5]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.93e-05 | 193 | 134 | 8 | 6789_UP | |
| Drug | Chlorzoxazone [95-25-0]; Down 200; 23.6uM; HL60; HG-U133A | 2.01e-05 | 194 | 134 | 8 | 1416_DN | |
| Drug | LY294002; Up 200; 10uM; MCF7; HG-U133A | 2.01e-05 | 194 | 134 | 8 | 258_UP | |
| Drug | Cefixime [79350-37-1]; Down 200; 8.8uM; HL60; HT_HG-U133A | 2.01e-05 | 194 | 134 | 8 | 1310_DN | |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; HL60; HT_HG-U133A | 2.08e-05 | 195 | 134 | 8 | 2394_UP | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 2.24e-05 | 197 | 134 | 8 | 5360_UP | |
| Drug | Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 2.32e-05 | 198 | 134 | 8 | 3785_DN | |
| Drug | Foliosidine [2520-38-9]; Up 200; 13uM; PC3; HT_HG-U133A | 2.32e-05 | 198 | 134 | 8 | 3739_UP | |
| Drug | Anilino | 2.43e-05 | 29 | 134 | 4 | CID000137550 | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 2.50e-05 | 200 | 134 | 8 | 3765_DN | |
| Drug | hypericin | 4.35e-05 | 108 | 134 | 6 | CID005281051 | |
| Drug | ethoxytriethyleneglycol | 4.39e-05 | 66 | 134 | 5 | CID000008190 | |
| Disease | Breast Carcinoma | RAD51C FLNA RPL31 SYNE1 CYP17A1 SHMT1 TERT PALB2 CRHR1 NCOR1 MFGE8 CLUL1 HERC2 | 7.99e-07 | 538 | 130 | 13 | C0678222 |
| Disease | Malignant neoplasm of breast | RAD51C FLNA RPL31 SYNE1 CYP17A1 SHMT1 TERT PALB2 CRHR1 CRYAA BMP1 NCOR1 MFGE8 NF1 PRKAA2 MAP7D2 CLUL1 HERC2 | 1.19e-06 | 1074 | 130 | 18 | C0006142 |
| Disease | Profound Mental Retardation | 2.88e-06 | 139 | 130 | 7 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.88e-06 | 139 | 130 | 7 | C0025363 | |
| Disease | Mental deficiency | 2.88e-06 | 139 | 130 | 7 | C0917816 | |
| Disease | Mammary Carcinoma, Human | RAD51C FLNA RPL31 SYNE1 CYP17A1 SHMT1 TERT PALB2 CRHR1 NCOR1 MFGE8 CLUL1 | 3.83e-06 | 525 | 130 | 12 | C4704874 |
| Disease | Mammary Neoplasms, Human | RAD51C FLNA RPL31 SYNE1 CYP17A1 SHMT1 TERT PALB2 CRHR1 NCOR1 MFGE8 CLUL1 | 3.83e-06 | 525 | 130 | 12 | C1257931 |
| Disease | Mammary Neoplasms | RAD51C FLNA RPL31 SYNE1 CYP17A1 SHMT1 TERT PALB2 CRHR1 NCOR1 MFGE8 CLUL1 | 3.98e-06 | 527 | 130 | 12 | C1458155 |
| Disease | Intellectual Disability | RALGAPA1 ZNF142 SYNE1 NSD1 CHD3 SIN3A NF1 PRKCG TAF2 ASCC3 MAN1B1 | 4.93e-06 | 447 | 130 | 11 | C3714756 |
| Disease | Glioblastoma Multiforme | 1.01e-05 | 111 | 130 | 6 | C1621958 | |
| Disease | level of carboxypeptidase A1 in blood serum | 5.76e-05 | 3 | 130 | 2 | OBA_2041112 | |
| Disease | hereditary breast ovarian cancer syndrome (is_implicated_in) | 1.91e-04 | 5 | 130 | 2 | DOID:5683 (is_implicated_in) | |
| Disease | cytochrome c oxidase subunit 6C measurement | 2.86e-04 | 6 | 130 | 2 | EFO_0801515 | |
| Disease | Cerebral ventriculomegaly | 3.99e-04 | 7 | 130 | 2 | C1531647 | |
| Disease | Hydrocephalus Ex-Vacuo | 3.99e-04 | 7 | 130 | 2 | C0270720 | |
| Disease | Communicating Hydrocephalus | 3.99e-04 | 7 | 130 | 2 | C0009451 | |
| Disease | Fetal Cerebral Ventriculomegaly | 3.99e-04 | 7 | 130 | 2 | C2936718 | |
| Disease | Post-Traumatic Hydrocephalus | 3.99e-04 | 7 | 130 | 2 | C0477432 | |
| Disease | Obstructive Hydrocephalus | 3.99e-04 | 7 | 130 | 2 | C0549423 | |
| Disease | Glioblastoma | 4.19e-04 | 79 | 130 | 4 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 5.28e-04 | 84 | 130 | 4 | C0334588 | |
| Disease | Congenital Hydrocephalus | 5.30e-04 | 8 | 130 | 2 | C0020256 | |
| Disease | microcephaly (is_implicated_in) | 5.30e-04 | 8 | 130 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | Aqueductal Stenosis | 5.30e-04 | 8 | 130 | 2 | C2936786 | |
| Disease | mitral valve prolapse (is_implicated_in) | 6.80e-04 | 9 | 130 | 2 | DOID:988 (is_implicated_in) | |
| Disease | Hydrocephalus | 6.80e-04 | 9 | 130 | 2 | C0020255 | |
| Disease | ductal carcinoma in situ (is_marker_for) | 6.80e-04 | 39 | 130 | 3 | DOID:0060074 (is_marker_for) | |
| Disease | Uterine leiomyoma | 7.15e-04 | 91 | 130 | 4 | HP_0000131 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 7.88e-04 | 41 | 130 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 7.88e-04 | 41 | 130 | 3 | C0858252 | |
| Disease | Asthma, Occupational | 8.47e-04 | 10 | 130 | 2 | C0264423 | |
| Disease | Drugs used in diabetes use measurement | 9.59e-04 | 255 | 130 | 6 | EFO_0009924 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 1.03e-03 | 11 | 130 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | Gastric Adenocarcinoma | 1.04e-03 | 45 | 130 | 3 | C0278701 | |
| Disease | Leukemia, Myelocytic, Acute | 1.04e-03 | 173 | 130 | 5 | C0023467 | |
| Disease | sexual dimorphism measurement | RALGAPA1 ZNF142 PHF20 PABPC4 NSD1 GRIN2A ZNF710 MEI4 MFGE8 NF1 SEC11A ZFHX3 EPB41L2 | 1.22e-03 | 1106 | 130 | 13 | EFO_0021796 |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.33e-03 | 49 | 130 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Fanconi anemia | 1.69e-03 | 14 | 130 | 2 | cv:C0015625 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 1.69e-03 | 14 | 130 | 2 | C0677776 | |
| Disease | Acute Cerebrovascular Accidents | 1.76e-03 | 54 | 130 | 3 | C0751956 | |
| Disease | cutaneous melanoma | 2.05e-03 | 121 | 130 | 4 | EFO_0000389 | |
| Disease | total lipids in medium HDL measurement | 2.16e-03 | 58 | 130 | 3 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 2.16e-03 | 58 | 130 | 3 | EFO_0022267 | |
| Disease | muscular dystrophy (is_implicated_in) | 2.51e-03 | 17 | 130 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Cerebrovascular accident | 2.61e-03 | 62 | 130 | 3 | C0038454 | |
| Disease | ischemia (biomarker_via_orthology) | 2.81e-03 | 18 | 130 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | Bone marrow hypocellularity | 2.81e-03 | 18 | 130 | 2 | C1855710 | |
| Disease | colorectal adenoma (is_marker_for) | 3.47e-03 | 20 | 130 | 2 | DOID:0050860 (is_marker_for) | |
| Disease | heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease, cancer | 3.47e-03 | 20 | 130 | 2 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004352, MONDO_0004992 | |
| Disease | haptoglobin measurement | 3.83e-03 | 21 | 130 | 2 | EFO_0004640 | |
| Disease | Colorectal Carcinoma | 3.99e-03 | 702 | 130 | 9 | C0009402 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ADKKTLETHIKIFHA | 116 | Q9H2P0 | |
| DEHVHSKLEGSKVTK | 1061 | Q5SW79 | |
| VKRKDFKEQVIHHFV | 201 | Q9HA82 | |
| GCHFHEVVKSKLSKE | 951 | A4D0V7 | |
| AIEHVAEKAKTALHK | 226 | Q5T601 | |
| KIGEHQLTGHKVAVK | 31 | P54646 | |
| VKSIVDFVKDHGNIK | 286 | P15085 | |
| QKKKIHLVFEFIDHT | 71 | Q8IVW4 | |
| KLVEHVKEHHKAFLA | 301 | Q9H211 | |
| NSIKHGENKTVTFKH | 516 | Q9UKA4 | |
| NKHVFKDKVVLDVGS | 106 | Q9NR22 | |
| GHFKGNVVAIKHVNK | 541 | P20594 | |
| VKFHSDDTITKKGFH | 956 | P13497 | |
| VKRKDFKEQIIHHVA | 201 | Q96G23 | |
| IQKYHSIKKIEHEGQ | 3161 | Q8IZT6 | |
| ESHHDFLVKVKVGKF | 351 | Q9UH62 | |
| HKAGGRHVAVKIVKN | 181 | P49759 | |
| KHKGEEHRKALEDFT | 186 | O43502 | |
| LKKAEHLDFKHVVFG | 3176 | P49792 | |
| VKKGHIQFEAHKDER | 511 | Q96L73 | |
| NEKGELKVSHKHFEE | 816 | O15381 | |
| LKVSHKHFEEAFKKV | 821 | O15381 | |
| LTFAKDHVKHQLTVK | 451 | Q8IXQ6 | |
| LDIIKHIVAKGEHKS | 101 | O95747 | |
| QLHADVGDKVKIIFK | 811 | P00450 | |
| KIKVGDRHISAHKFV | 71 | Q9P2R3 | |
| KGFVLHKSKSEEAHA | 321 | Q8NC51 | |
| HHAKKEAAQKVGAVA | 626 | Q13310 | |
| AIKVSVHPQSKKEHA | 316 | O75121 | |
| GKDKEKESTVHIETH | 841 | O60524 | |
| EKHVVDKHASEKHAA | 361 | Q96T17 | |
| FIHDVNKKHKEFVGN | 171 | Q08431 | |
| HVFIKKVAVNSGGKH | 4036 | O95714 | |
| QHKEFQKSLGAKHSV | 6746 | Q03001 | |
| ENTKEKAAGFHKVVH | 21 | Q8NI77 | |
| KAAGFHKVVHVVDKH | 26 | Q8NI77 | |
| DGGDIHIHKKKSQQV | 126 | Q6ICG6 | |
| EHQLSVAGKIKKHFN | 656 | O15075 | |
| KHAKGQVLFDKVCEH | 236 | O43491 | |
| HKEVKSHLKEIQSAF | 976 | Q5VYK3 | |
| EKHGKVAHKQVAAEL | 41 | Q70Z53 | |
| HSKFIKVHNEATGKS | 161 | P98177 | |
| KIREHDVSKAHGKIQ | 206 | Q9HCI6 | |
| AHVGKHIFEECIKKT | 666 | Q96J66 | |
| RQKVVHEVKSHKFTA | 26 | P05129 | |
| ASHVLEVKNVKKEVH | 706 | Q9Y5S2 | |
| VNFEKHEEAQKAVVH | 236 | Q4VXU2 | |
| KESHFVFSKQGKHLE | 1486 | Q9C091 | |
| KKEHVNVVFIGHVDA | 71 | P15170 | |
| KFQEAVEKVTQHIHG | 416 | Q9UKM7 | |
| AGTEVELEKSQKHKH | 1751 | Q7Z6E9 | |
| EAVIQSHLDVKKKGF | 426 | Q86YC2 | |
| FFHAKKEVKIEHQPV | 3121 | Q4G0P3 | |
| KKHAVAIIFHDETSK | 76 | Q6PKX4 | |
| FVPKETGEHLVHVKK | 2011 | P21333 | |
| SLVKKKVQEFEHING | 1496 | Q12873 | |
| KTHSDGKIAVEVHKS | 501 | Q96ST8 | |
| VGHHQLAKEVLIKKG | 76 | P05093 | |
| NEKFAEVGVKAHHLI | 741 | Q9BYX4 | |
| LNEEKKSKVHYHVAV | 106 | P34998 | |
| VNGIVKHFHKPEKER | 1116 | Q6IQ26 | |
| KCEDKAIHHFIEGVK | 386 | P09913 | |
| TVKVQDDFVEIHGKH | 86 | P02489 | |
| VNKHKDLKTHGFTLE | 681 | P20807 | |
| HKEKFKTGLIHSADD | 1141 | Q9P225 | |
| SIFTKEKEHEALHKE | 576 | Q9Y2H2 | |
| FLVAKSRQVDHHEKK | 1766 | Q8TDX9 | |
| KKAKFHQTEGDHLTL | 1031 | Q14562 | |
| QTVKHIHVKAFSKDQ | 126 | Q9BVI0 | |
| KDFQKVAHFIHRGIE | 416 | P34896 | |
| KFVKISIHDHEKQQL | 126 | Q8TC56 | |
| IGHDDQEIKKFLQKH | 336 | A8MW99 | |
| TSDHKSKVKEIVAQH | 1006 | Q15147 | |
| KEHVFSLEAKVKDHE | 3911 | Q8NF91 | |
| EFKSQEHAKHKGPKV | 856 | P12259 | |
| HGLLKTFVKQTDHIK | 196 | Q9NXC2 | |
| LRQKNVHEVKDHKFI | 26 | P17252 | |
| HDKGTHVEVNVKIKK | 536 | Q9HB63 | |
| HHFVNKKFGNLVETK | 246 | Q9H0K6 | |
| HSEKKIHRDIKAANV | 136 | Q9P289 | |
| KHVDELKVLKIHINF | 136 | Q6P1X5 | |
| GIIQKIVDSHKVKHV | 66 | Q05397 | |
| TDHEKEIFKDKFIQH | 441 | O75376 | |
| GRVHLVKEKTAKHFF | 61 | O43930 | |
| ILENHKFTKESHGKL | 151 | O95343 | |
| HHVKRQTGIQKEDKY | 796 | Q96ST3 | |
| DKLEKIHHSGAKVVL | 276 | Q99832 | |
| HVKHELAEIVFKVGK | 76 | Q9Y2R5 | |
| HVGKHVFEECIKKTL | 636 | Q96J65 | |
| KKHKSEHVFQILFGI | 271 | Q9UIY3 | |
| ARVQAIHQEHKKEKG | 376 | Q86YF9 | |
| FGKELHKVEGHIQDK | 276 | Q9H1P3 | |
| HKAHQVVKKASGDKI | 166 | Q9H190 | |
| EFVRKHIFNKHAEKI | 726 | Q9BXP5 | |
| HIFNKHAEKIEEVKK | 731 | Q9BXP5 | |
| HEQRKVHAEKVAKAF | 281 | Q6PD74 | |
| FHLKDSVGHKETKAI | 101 | Q8N3C0 | |
| VVAKALQHFKEHFKT | 451 | Q15846 | |
| VEHVKSQGHKDKAKE | 701 | Q9ULV3 | |
| KKKSVFVVHKRIHAG | 291 | Q5HYK9 | |
| FKKSNLIIHQKIHTG | 306 | Q6P2D0 | |
| GTAEEHKAHIRKKTD | 331 | Q9HA65 | |
| KSFQRHEKTHTGEKL | 471 | Q8IYI8 | |
| QKSNVIDHEKIHTGK | 346 | Q96PE6 | |
| VQHGKIDSDVKHDCK | 176 | Q8NDQ6 | |
| KQNLIEHEKIHTGEK | 346 | Q3ZCX4 | |
| LKQHTEEKEFVEKHF | 1726 | Q6GYQ0 | |
| TINIHKRIHGVGFKK | 26 | P62899 | |
| EKKVQGNKDHIILEH | 641 | O15394 | |
| VGHLKTIADHSEKNK | 1036 | Q9P227 | |
| ANLTKHKVIHTGEKQ | 521 | P0DKX0 | |
| HSLTHKGVKEFKCEV | 481 | Q8N1W2 | |
| HQVHEKEEFKALKTL | 1576 | P21359 | |
| IHEKQNGHIKFLTKG | 101 | P67812 | |
| GRVHLVKEKTAKHFF | 61 | P51817 | |
| NVGSILIQHHKKEKF | 256 | Q9BQI6 | |
| DKSIHVKLDVGKLHT | 361 | O15195 | |
| ISSEKHKEKVFHTED | 876 | Q8IWR0 | |
| HKQDIVKPEKTVSHG | 541 | Q13061 | |
| FSILAKHKVIHTGEK | 1181 | O43345 | |
| KAFSHKHILVEHQKI | 456 | Q8NEK5 | |
| GEFVEHHKIKATNKK | 276 | Q86VQ6 | |
| GKAFIHDSQLKEHKR | 266 | Q12901 | |
| KDHLIQHQKTHTGEK | 556 | Q9Y2H8 | |
| LIEHRKVHTKKTAFG | 231 | O75362 | |
| KAFIKHLKETHGVRA | 301 | P52746 | |
| KTGNVVKRFKGHEHE | 91 | Q8NA23 | |
| VKRFKGHEHEITKVA | 96 | Q8NA23 | |
| HKLINKVDKTHEFTE | 436 | Q9Y462 | |
| KGKHKDECHNFIKVF | 111 | Q8NFY4 | |
| DHVFKHPVHIAKNIK | 541 | Q8NA31 | |
| VVQKAAHGHVRKAFK | 746 | O14746 | |
| KSQFKEHQRIHTGEK | 571 | Q9Y473 | |
| KTKLVEHQRSHTGEK | 431 | Q8IZ26 | |
| DKHVQKYQLVAHIKE | 1006 | Q15911 | |
| NKEIVHTFKGHKAEI | 151 | Q8NI36 | |
| EKLEEKVGKHAHFET | 481 | Q8N1T3 | |
| IHGVHIEEKKKSPDF | 871 | Q12879 |